IPC-klasse
Fullmektig i Norge:
Org.nummer: 979993269
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2008.01.31, EP 08300061
2008.08.20, EP 08162683
Christian Dejaco ET AL: "Imbalance of regulatory T cells in human autoimmune diseases", Immunology, vol. 117, no. 3, 1 March 2006 (2006-03-01) , pages 289-300, XP055100105, ISSN: 0019-2805, DOI: 10.1111/j.1365-2567.2005.02317.x (B1)
WO-A-2006/111986 (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US January 2009 MUNKONDA MERCEDES N ET AL: 'Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3' Database accession no. PREV200900111448 & FEBS JOURNAL, vol. 276, no. 2, January 2009 (2009-01), pages 479-496, ISSN: 1742-464X(print), DOI: 10.1111/J.1742-4658.2008.06797.X (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US July 2005 KOZIEL MARGARET JAMES: 'Cellular immune responses against hepatitis C virus' Database accession no. PREV200510077570 & KOZIEL MARGARET JAMES: "Cellular immune responses against hepatitis C virus", CLINICAL INFECTIOUS DISEASES, vol. 41, no. Suppl. 1, July 2005 (2005-07) , pages S25-S31, ISSN: 1058-4838 (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US June 2007 PEREZ-DIEZ AINHOA ET AL: 'CD4 cells can be more efficient at tumor rejection than CD8 cells' Database accession no. PREV200700458685 & BLOOD, vol. 109, no. 12, June 2007 (2007-06), pages 5346-5354, ISSN: 0006-4971, DOI: 10.1182/BLOOD-2006-10-051318 (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US March 2010 QUEZADA SERGIO A ET AL: 'Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts' Database accession no. PREV201000196145 & JOURNAL OF EXPERIMENTAL MEDICINE, vol. 207, no. 3, March 2010 (2010-03), pages 637-650, ISSN: 0022-1007, DOI: 10.1084/JEM.20091918 (B1)
DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US 01 December 2000 MARZO A L ET AL: 'Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.' Database accession no. NLM11086036 & MARZO A L ET AL: "Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 DEC 2000, vol. 165, no. 11, 1 December 2000 (2000-12-01), pages 6047-6055, ISSN: 0022-1767 (B1)
DEAGLIO SILVIA ET AL: "Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression" JOURNAL OF EXPERIMENTAL MEDICINE, vol. 204, no. 6, June 2007 (2007-06), pages 1257-1265, XP002485581 ISSN: 0022-1007 (B1)
DWYER ET AL.: "CD39 and control of cellular immune responses" PURINERGIC SIGNALLING, vol. 3, 6 February 2007 (2007-02-06), pages 171-180, XP002485580 (B1)
MÖLLER SINA ET AL: "Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation." PURINERGIC SIGNALLING SEP 2007, vol. 3, no. 4, September 2007 (2007-09), pages 359-366, XP019558228 ISSN: 1573-9538 (B1)
PAPAGNO ET AL.: "Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection", PLOS BIOLOGY, vol. 2, February 2004 (2004-02), pages 173-185, (B1)
SCHETINGER MARIA ROSA C ET AL: "NTPDase and 5 '-nucleotidase activities in physiological and disease conditions: New perspectives for human health" BIOFACTORS, vol. 31, no. 2, 2007, pages 77-98, XP009116149 ISSN: 0951-6433 (B1)
SCHLOSSMANN ET AL., 1995, OXFORD UNIVERSITY PRESS, NEW YORK deel GOUTTEFANGEAS ET AL.: 'Biochemical analysis and epitope mapping of mAb defining CD39', pages 383 - 385, XP009183240 (B1)
SHEVACH ETHAN M ET AL: "The lifestyle of naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells" IMMUNOLOGICAL REVIEWS, vol. 212, August 2006 (2006-08), pages 60-73, XP002485582 ISSN: 0105-2896 (B1)
US-A1- 2005 037 382 (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US 20 July 1999 MUMBERG DOMINIK ET AL: 'CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma' Database accession no. PREV199900384577 & MUMBERG DOMINIK ET AL: "CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 96, no. 15, 20 July 1999 (1999-07-20) , pages 8633-8638, ISSN: 0027-8424 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
Patent opphørt | Ikke betalt årsavgift |
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
EP Opphørt for ikke betalt årsavgift (3206)
|
Utgående
EP Påminnelse om ikke betalt årsavgift (3331) (PTEP2238170)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende, AR183606210
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 11. avg. år (EP) | 2019.01.29 | 3500 | COMPUTER PACKAGES INC | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2018.01.29 | 3200 | COMPUTER PACKAGES INC | Betalt og godkjent |
31703227 expand_more expand_less | 2017.03.08 | 5500 | Bryn Aarflot AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
Årsavgift 9. avg. år (EP) | 2017.01.27 | 2850 | Computer Packages Inc | Betalt og godkjent |